This policy report addresses federal hemp protections, medical-cannabis access for veterans, cannabinoid research, and the need for coordinated physician-guided care. It combines a patient-centered policy argument with longitudinal clinical documentation, historical public advocacy, international agricultural and herbal knowledge, disability-related functional evidence, and original scholarship concerning cannabinoid use and psychoaffective outcomes. The report distinguishes nonintoxicating CBD use from THC-related clinical and regulatory questions and argues that patient testimony should inform, but not replace, rigorous scientific research. It requests support for immediate federal protections preventing disruption of lawful hemp access and for legislation permitting Department of Veterans Affairs physicians to recommend medical cannabis where state law allows. Supporting exhibits document four VA medical records across three specialties describing CBD use or reported functional benefit, a long-standing therapeutic and policy relationship involving Jamaican herbalist and certified commercial organic farmer Collin Artwell, historical medical-marijuana advocacy, and two related scholarly publications archived through Zenodo.